RCT01437: Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial


The purpose of this study is to find out if using a computer program (called iDose) to guide infliximab dosing is more effective and safer than using standard infliximab dosing over 52 weeks. All patients in this study will be receiving infliximab as part of their medical care, this study is only looking at two different methods of determining the dose and timing of administration.

I'm interested

18 Years and over
This study is NOT accepting healthy volunteers

Crohn Disease, Digestive & Liver Health

Clinics and Surgery Center (CSC)

Beiqing Wu -
Byron Vaughn
Phase IV
See this study on